Target intelligence / Profile preview

TRD antisense RNA 1 (TRD-AS1)

Target
TRD-AS1
Molecular classification
Other, lncRNA, long non-coding RNA
01

Overview

TRD antisense RNA 1 (TRD-AS1) is a human long non-coding RNA (lncRNA) gene, classified as an RNA gene with antisense orientation to a neighboring gene[3]. Like other antisense lncRNAs, TRD-AS1 is presumed to participate in the regulation of gene expression, typically by interacting with sense transcripts or influencing chromatin structure, although specific functional details or disease relevance have not been characterized for this gene in the available scientific literature[1][3]. There is no evidence that TRD-AS1 acts as a classical therapeutic target (such as a receptor, enzyme, transporter, or known pathway component), nor are there data implicating direct interactions with drugs, defined mechanisms of drug action, or biomarker utility for patient selection or efficacy monitoring. TRD antisense RNA 1 remains a member of the broadly defined non-coding RNA molecular family, recognized for their regulatory, rather than protein-coding, roles in biology[1][3].

Other names
TRD-AS1
02

Biological functions

Gene expression regulation
03

Disease associations

Other (No direct disease association or therapeutic targeting is established for this molecule as of now)

Beyond the preview

Go deeper on TRD antisense RNA 1 (TRD-AS1).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on TRD antisense RNA 1 (TRD-AS1).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call